NPASS Compound

Structure

NPC489714 OpenBabel06302215242D 23 25 0 0 1 0 0 0 0 0999 V2000 4.1772 3.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5089 2.6514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4564 2.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8932 1.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1288 0.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3150 0.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2509 -0.4909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5764 1.0843 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.8610 1.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7932 0.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8327 0.4808 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.0000 0.9615 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.0674 2.5612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4406 1.8162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3492 2.7734 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.2452 3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1538 3.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1081 4.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0883 3.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7518 2.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9338 1.9769 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.2419 3.1307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 4 21 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 6 8 1 0 0 0 0 8 21 1 0 0 0 0 8 9 1 1 0 0 0 8 10 1 0 0 0 0 11 10 1 6 0 0 0 11 12 1 0 0 0 0 11 23 1 0 0 0 0 12 13 1 6 0 0 0 12 14 1 0 0 0 0 12 23 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 15 22 1 1 0 0 0 16 17 2 0 0 0 0 17 18 1 0 0 0 0 17 19 1 0 0 0 0 19 20 1 0 0 0 0 21 20 1 1 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	318.22
Volume:	347.268
LogP:	3.062
LogD:	2.384
LogS:	-4.603
# Rotatable Bonds:	1
TPSA:	49.83
# H-Bond Aceptor:	3
# H-Bond Donor:	1
# Rings:	3
# Heavy Atoms:	3

MedChem Properties

QED Drug-Likeness Score:	0.591
Synthetic Accessibility Score:	5.167
Fsp3:	0.75
Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Rejected
GSK Rule:	Accepted
BMS Rule:	0
Golden Triangle Rule:	Accepted
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-4.723
MDCK Permeability:	2.7163498089066707e-05
Pgp-inhibitor:	0.998
Pgp-substrate:	0.216
Human Intestinal Absorption (HIA):	0.01
20% Bioavailability (F20%):	0.767
30% Bioavailability (F30%):	0.096

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.383
Plasma Protein Binding (PPB):	94.57286834716797%
Volume Distribution (VD):	2.039
Pgp-substrate:	4.115800380706787%

ADMET: Metabolism

CYP1A2-inhibitor:	0.02
CYP1A2-substrate:	0.383
CYP2C19-inhibitor:	0.085
CYP2C19-substrate:	0.906
CYP2C9-inhibitor:	0.165
CYP2C9-substrate:	0.059
CYP2D6-inhibitor:	0.016
CYP2D6-substrate:	0.082
CYP3A4-inhibitor:	0.568
CYP3A4-substrate:	0.64

ADMET: Excretion

Clearance (CL):	5.261
Half-life (T1/2):	0.117

ADMET: Toxicity

hERG Blockers:	0.03
Human Hepatotoxicity (H-HT):	0.436
Drug-inuced Liver Injury (DILI):	0.097
AMES Toxicity:	0.047
Rat Oral Acute Toxicity:	0.35
Maximum Recommended Daily Dose:	0.955
Skin Sensitization:	0.69
Carcinogencity:	0.458
Eye Corrosion:	0.005
Eye Irritation:	0.392
Respiratory Toxicity:	0.953

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC489714

Natural Product ID:	NPC489714
*Common Name:**	ZKFQUXJPKUAAGK-IXADISSCSA-N
IUPAC Name:	n.a.
Synonyms:
Standard InCHIKey:	ZKFQUXJPKUAAGK-IXADISSCSA-N
Standard InCHI:	InChI=1S/C20H30O3/c1-12(2)15-9-17(22)19(4)11-18-20(5,23-18)10-14(21)8-13(3)6-7-16(15)19/h8-9,12,14,16,18,21H,6-7,10-11H2,1-5H3/b13-8+/t14-,16-,18-,19+,20-/m0/s1
SMILES:	CC(C)C1=CC(=O)[C@]2(C)C[C@H]3[C@](C)(C[C@H](/C=C(C)/CC[C@@H]12)O)O3
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	n.a.
PubChem CID:	n.a.
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0004603] Organic oxygen compounds [CHEMONTID:0000323] Organooxygen compounds [CHEMONTID:0000129] Alcohols and polyols [CHEMONTID:0001661] Secondary alcohols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[24387683]
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	Niphates recondita	Weizhou Island, Beibuwan Bay, Guangxi,China	n.a.	PMID[24387683]
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[28530828]
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[31265296]
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[32966070]
NPO2453	Stachybotrys chartarum	Species	Stachybotryaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
MIC	7

Activity Type	# Activity
Organism	7

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT19	Organism	Escherichia coli	Escherichia coli	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT747	Organism	Acinetobacter baumannii	Acinetobacter baumannii	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT18	Organism	Pseudomonas aeruginosa	Pseudomonas aeruginosa	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT173	Organism	Klebsiella pneumoniae	Klebsiella pneumoniae	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT16	Organism	Staphylococcus aureus	Staphylococcus aureus	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT175	Organism	Enterococcus faecalis	Enterococcus faecalis	MIC	>=	100.0	ug.mL-1	PMID[31265296]
NPT20	Organism	Candida albicans	Candida albicans	MIC	>=	100.0	ug.mL-1	PMID[31265296]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC489714 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	200
0.1-0.2	1327
0.2-0.3	5676
0.3-0.4	12844
0.4-0.5	11267
0.5-0.6	6998
0.6-0.7	3758
0.7-0.8	603
0.8-0.85	20
0.85-0.9	1
0.9-0.95	2
0.95-1	1

Similarity Score	Similarity Level	Natural Product ID

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC489714 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	195
0.1-0.2	2032
0.2-0.3	3944
0.3-0.4	2100
0.4-0.5	508
0.5-0.6	244
0.6-0.7	123
0.7-0.8	4
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data